Protection of trinitrobenzene sulfonic acid-induced colitis by an interleukin 2-IgG2b fusion protein in mice

Gastroenterology

Volumn 117, Issue 4, 1999, Pages 866-876

  Stallmach, A ^a   Wittig, B ^a   Giese, T ^a   Pfister, K ^a   Hoffmann, J C ^a   Bulfone Paus, S ^a   Kunzendorf, U ^a   Meuer, S C ^a   Zeitz, M ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; IMMUNOGLOBULIN G2B; INTERLEUKIN 2; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG SCREENING; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOPHARMACOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE SUBPOPULATION; WASTING SYNDROME;

EID: 0032884525     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(99)70345-8     Document Type: Article

References (53)

1. C Fiocchi Inflammatory bowel disease: etiology and pathogenesis Gastroenterology 115 1998 182 205
2. R Duchmann E Schmitt P Knolle K-H Meyer zum Büschenfelde M Neurath Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12 Eur J Immunol 26 1996 934 938
3. M Zeitz Pathogenesis of inflammatory bowel disease Digestion 58 suppl1 1997 59 61
4. A Stallmach F Schafer S Hoffmann S Weber I Muller-Molaian T Schneider G Kohne KW Ecker G Feifel M Zeitz Increased state of activation of CD4 positive T cells and elevated interferon gamma production in pouchitis Gut 43 1998 499 505
5. B Gulwani-Akolkar PN Akolkar A Minassian R Pergolizzi M McKinley G Mullin S Fisher J Silver Selective expansion of specific T cell receptors in the inflamed colon of Crohn's disease J Clin Invest 98 1996 1344 1354
6. CS Probert A Chott JR Turner LJ Saubermann AC Stevens K Bodinaku CO Elson SP Balk RS Blumberg Persistent clonal expansions of peripheral blood CD4+ lymphocytes in chronic inflammatory bowel disease J Immunol 157 1996 3183 3191
7. + T cells Am J Pathol 148 1996 1503 1515
8. MH Claesson A Rudolphi S Kofoed SS Poulsen J Reimann CD4+ T lymphocytes injected into severe combined immunodeficient (SCID) mice lead to an inflammatory and lethal bowel disease Clin Exp Immunol 104 1996 491 500
9. HL Weiner A Friedman A Miller SJ Khoury A al-Sabbagh L Santos M Sayegh RB Nussenblatt DE Trentham DA Hafler Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens Annu Rev Immunol 12 1994 809 837
10. T Marth W Strober BL Kelsall High dose oral tolerance in ovalbumin TCR-transgenic mice: systemic neutralization of IL-12 augments TGF-beta secretion and T cell apoptosis J Immunol 157 1996 2348 2357
11. E Breese CP Braegger CJ Corrigan JA Walker-Smith TT MacDonald Interleukin-2- and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa Immunology 78 1993 127 131
12. IJ Fuss M Neurath M Boirivant JS Klein C de la Motte SA Strong C Fiocchi W Strober Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5 J Immunol 157 1996 1261 1270
13. P Parronchi P Romagnani F Annunziato S Sampognaro A Becchio L Giannarini E Maggi C Pupilli F Tonelli S Romagnani Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease Am J Pathol 150 1997 823 832
14. M Robinson Optimizing therapy for inflammatory bowel disease Am J Gastroenterol 92 suppl 1997 12S 17S
15. DJ Lenschow Y Zeng JR Thistlethwaite A Montag W Brady MG Gibson PS Linsley JA Bluestone Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg [see comments] Science 257 1992 789 792
16. LA Turka PS Linsley H Lin W Brady JM Leiden RQ Wei ML Gibson XG Zheng S Myrdal D Gordon LA Turka PS Linsley H Lin W Brady JM Leiden RQ Wei ML Gibson XG Zheng S Mydral D Gordon T Bailey SF Bolling CB Thompson T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo Proc Natl Acad Sci USA 89 1992 11102 11105
17. WM Bogers F Lang KE Parker B Le Mauff I Anegon Y Jacques JP Soulillou Rat interleukin-2 immunoglobulin M fusion proteins are cytotoxic in vitro for cells expressing the IL-2 receptor and can abolish cell-mediated immunity in vivo Transplantation 58 1994 932 939
18. BK Finck PS Linsley D Wofsy Treatment of murine lupus with CTLA4Ig Science 265 1994 1225 1227
19. MF Neurath I Fuss B Kelsall KH Meyer zum Büschenfelde W Strober Effect of IL-12 and antibodies to IL-12 on established granulomatous colitis in mice Ann NY Acad Sci 795 1996 368 370
20. MF Neurath S Pettersson K-H Meyer zum Büschenfelde W Strober Local administration of antisense phosphorothioate oligo-nucleotides to the p65 subunit of NF-kappa B abrogates estab-lished experimental colitis in mice Nat Med 2 1996 998 1004
21. U Kunzendorf T Pohl S Bulfone-Paus H Krause M Notter A Onu G Walz T Diamantstein Suppression of cell-mediated and humoral immune responses by an interleukin-2-immunoglobulin fusion protein in mice J Clin Invest 97 1996 1204 1210
22. R Rückert U Herz D Ungureanu T Pohl H Renz S Bulfone-Paus IL-15-IgG2b fusion protein accelerates and enhances a Th2 but not Th1 immune response in vivo, while IL-2–IgG2b fusion protein inhibits both Eur J Immunol 28 1998 3312 3320
23. MF Neurath I Fuss BL Kelsall E Stuber W Strober Antibodies to interleukin 12 abrogate established experimental colitis in mice J Exp Med 182 1995 1281 1290
24. B Wittig C Schwarzler N Fohr U Gunthert M Zoller Curative treatment of an experimentally induced colitis by a CD44 variant V7-specific antibody J Immunol 161 1998 1069 1073
25. TJ Dengler JC Hoffmann P Knolle M Albert-Wolf M Roux R Wallich SC Meuer Structural and functional epitopes of the human adhesion receptor CD58 (LFA-3) Eur J Immunol 22 1992 2809 2817
26. M Vieth A Will K Schroppel M Röllinghoff A Gessner Interleu-kin-10 inhibits antimicrobial activity against Leishmania major in murine macrophages Scand J Immunol 40 1994 403 409
27. HF Savelkoul AC Vossen EG Breedland GJ Tibbe Semi-preparative purification and validation of monoclonal antibodies for immunotherapy in mice J Immunol Methods 172 1994 33 42
28. B Seed A Aruffo Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure Proc Natl Acad Sci USA 84 1987 3365 3369
29. T Schneider HU Jahn W Schmidt EO Riecken M Zeitz R Ullrich Loss of CD4 T lymphocytes in patients infected with human immunodeficiency virus type 1 is more pronounced in the duodenal mucosa than in the peripheral blood Berlin Diarrhea/Wasting Syndrome Study Group Gut 37 1995 524 529
30. P Openshaw EE Murphy NA Hosken V Maino K Davis K Murphy A O'Garra Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations J Exp Med 182 1995 1357 1367
31. + T cell with a type 1 cytokine profile Int Immunol 8 1996 1453 1461
32. U Schauer T Jung N Krug A Frew Measurement of intracellular cytokines Immunol Today 17 1997 305 306
33. AM Wang MV Doyle DF Mark Quantitation of mRNA by the polymerase chain reaction Proc Natl Acad Sci USA 86 1989 9717 9721
34. EP Zhang T Pohl S Bulfone-Paus U Kunzendorf F Hoffmann Prolongation of corneal allograft survival by an interleukin-2-immunoglobulin fusion protein in mice Graefes Arch Clin Exp Ophtalmol 236 1998 486 492
35. R Kühn J Lohler D Rennick K Rajewsky W Müller Interleukin-10–deficient mice develop chronic enterocolitis Cell 75 1993 263 274
36. + T cells Immunity 1 1994 553 562
37. KA Ribbons JH Thompson X Liu K Pennline DA Clark MJS Miller Anti-inflammatory properties of interleukin-10 adminstration in hapten-induced colitis Eur J Phramacol 323 1997 245 254
38. + T cell subset inhibits antigen-specific T-cell response and prevents colitis Nature 389 1997 737 741
39. CA Akdis T Blesken M Akdis B Wütherich K Blaser Role of interleukin 10 in specific immunotherapy J Clin Invest 102 1998 98 106
40. S Nikolaus J Bauditz P Gionchetti C Witt H Lochs H Schreiber Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation Gut 42 1998 470 476
41. SJH van Deventer CO Elson RN Fedorak Group. aCDS Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease Gastroenterology 113 1997 383 389
42. AE Chernoff EV Granowitz L Shapiro E Vannier G Lonnemann JB Angel JS Kennedy AR Rabson SM Wolff CA Dinarello A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses J Immunol 154 1995 5492 5499
43. SL Pender EJ Breese U Gunther D Howie NC Wathen D Schuppan TT MacDonald Suppression of T cell–mediated injury in human gut by interleukin 10: role of matrix metalloproteinases Gastroenterology 115 1998 573 583
44. FS Sutterwala GJ Noel R Clynes DM Mosser Selective suppression of interleukin-12 induction after macrophage receptor ligation J Exp Med 185 1997 1977 1985
45. FS Sutterwala GJ Noel P Salgame DM Mosser Reversal of proinflammatory responses by ligating the macrophage Fcgamma receptor type I J Exp Med 188 1998 217 222
46. MF Neurath I Fuss BL Kelsall DH Presky W Waegell W Strober Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta–mediated oral tolerance J Exp Med 183 1996 2605 2616
47. + T cells J Exp Med 183 1996 2669 2674
48. W Strober B Kelsall I Fuss T Marth B Ludviksson R Ehrhardt M Neurath Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation Immunol Today 18 1997 61 64
49. XX Zheng AW Steele PW Nickerson W Steurer J Steiger TB Strom Administration of noncytolytic IL-10/Fc in murine models of lipopolysaccharide-induced septic shock and allogeneic islet transplantation J Immunol 154 1995 5590 5600
50. A Bousvaros AC Stevens TB Strom J Murphy JT Lamont Interleukin-2 fusion protein (DAB389IL-2) selectively targets activated human peripheral blood and lamina propria lymphocytes Dig Dis Sci 42 1997 1542 1548
51. ER Kearney KA Pape DY Loh MK Jenkins Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo Immunity 1 1994 327 339
52. PS Linsley PM Wallace J Johnson MG Gibson JL Greene JA Ledbetter C Singh MA Tepper Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule Science 257 1992 792 795
53. P Baliga KD Chavin L Qin J Woodward J Lin PS Linsley JS Bromberg CTLA4Ig prolongs allograft survival while suppressing cell-mediated immunity Transplantation 58 1994 1082 1090